Posted on January 13th, 2012 by Health News
Jefferson’s Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually survival for locally advanced prostate cancer patients.
No Comments »
Filed under: Pharmacy News
Posted on January 11th, 2012 by Health News
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy “bait” is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women’s Hospital (BWH) Department of Anesthesiology [...]
No Comments »
Filed under: Pharmacy News
Posted on January 10th, 2012 by Health News
The controversial Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial has longer follow-up and more controversy. Medscape Medical News
No Comments »
Filed under: General Health News
Posted on December 31st, 2011 by Health News
Amgen (NASDAQ: AMGN) announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing [...]
No Comments »
Filed under: Pharmacy News
Posted on December 30th, 2011 by Health News
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
No Comments »
Filed under: Pharmacy News
Posted on December 8th, 2011 by Health News
(MedPage Today) — Active surveillance is a viable option that should be offered to low-risk patients, according to a draft statement issued by the panel.
No Comments »
Filed under: General Health News
Posted on November 29th, 2011 by Health News
New research led by the University of California, San Francisco (UCSF), offers further evidence of a link between aggressive prostate cancer and meat consumption, and suggests it is driven largely by consumption of grilled or barbecued red meat, especially when it is well-done…
No Comments »
Filed under: Men's Health
Posted on November 24th, 2011 by Health News
(MedPage Today) — The Medicare and Medicaid programs will pay physician practices for the costs of infusing the prostate cancer vaccine sipuleucel-T (Provenge) as well as reimbursing for the drug itself, drugmaker Dendreon announced Monday.
No Comments »
Filed under: General Health News
Posted on November 23rd, 2011 by Health News
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.
No Comments »
Filed under: Pharmacy News
Posted on November 23rd, 2011 by Health News
In Medicare news, the drug maker Dendreon says federal officials have said they will pay doctors to administer the drug. Also, policymakers are studying Medigap to see if curbs on those policies could help cut Medicare costs.
No Comments »
Filed under: Pharmacy News
